Protagenic Therapeutics (PTIX) — Tangible Net Worth Ratio
Protagenic Therapeutics (PTIX) has a Tangible Net Worth Ratio of 100.0% as of December 2024. This metric is calculated by deducting intangible assets ($0.00) from net assets ($1.01 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Protagenic Therapeutics short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Protagenic Therapeutics Tangible Net Worth Ratio (1995–2024)
This chart shows how Protagenic Therapeutics's Tangible Net Worth Ratio has changed across 21 annual periods from 1995 to 2024. As of December 2024, the ratio stands at 100.0%, reflecting net assets of $1.01 Million with intangible assets of $0.00 USD. See defensive interval ratio of Protagenic Therapeutics to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Protagenic Therapeutics (1995–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Protagenic Therapeutics from 1995 to 2024, covering 21 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see PTIX company net worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | $1.01 Million | $0.00 | $1.96 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $3.67 Million | $0.00 | $4.32 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $6.92 Million | $0.00 | $8.04 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $9.94 Million | $0.00 | $11.06 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $1.22 Million | $0.00 | $1.78 Million | ▲ +0.0 pp |
| 2016 | 100.0% | $2.48 Million | $0.00 | $3.16 Million | ▲ +37.7 pp |
| 2010 | 62.3% | $8.17 Million | $3.08 Million | $19.34 Million | ▼ -9.1 pp |
| 2009 | 71.4% | $25.35 Million | $7.25 Million | $44.60 Million | ▼ -5.7 pp |
| 2008 | 77.1% | $54.65 Million | $12.51 Million | $78.76 Million | ▼ -19.3 pp |
| 2007 | 96.4% | $16.86 Million | $599.00K | $23.96 Million | ▼ -3.6 pp |
| 2006 | 100.0% | $1.22 Million | $0.00 | $5.49 Million | ▲ +0.0 pp |
| 2004 | 100.0% | $2.74 Million | $0.00 | $6.95 Million | ▲ +0.0 pp |
| 2003 | 100.0% | $4.98 Million | $0.00 | $13.74 Million | ▲ +0.0 pp |
| 2002 | 100.0% | $12.87 Million | $0.00 | $21.53 Million | ▲ +0.0 pp |
| 2001 | 100.0% | $13.57 Million | $0.00 | $23.27 Million | ▲ +0.0 pp |
| 2000 | 100.0% | $13.86 Million | $0.00 | $22.92 Million | ▲ +0.0 pp |
| 1999 | 100.0% | $13.27 Million | $0.00 | $22.93 Million | ▲ +0.0 pp |
| 1998 | 100.0% | $13.95 Million | $0.00 | $21.48 Million | ▲ +0.0 pp |
| 1997 | 100.0% | $13.30 Million | $0.00 | $15.77 Million | ▲ +0.0 pp |
| 1996 | 100.0% | $7.04 Million | $0.00 | $12.57 Million | ▲ +0.0 pp |
| 1995 | 100.0% | $7.51 Million | $0.00 | $11.08 Million | — |